FUP.F Fuji Pharma Co. Ltd

Healthcare Pharmaceuticals Frankfurt Exchange
10.50 EUR
Close of Nov 12, 2026
8.88 13.27
Market cap
EUR 274M
P/E
15.4x
P/B
0.95x
ROE
4.7%
Dividend yield
2.62%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is FUP.F undervalued?

Graham number
Price10.50
Graham value13.03
Discount19.4%

FUP.F trades 19.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fuji Pharma Co. Ltd fundamental analysis

No fundamental analysis for Fuji Pharma Co. Ltd yet.

Fuji Pharma Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fuji Pharma Co. Ltd

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Ph…

Full company profile